Cancer surveillance in inflammatory bowel disease.

被引:12
作者
Bernstein C.N. [1 ]
机构
[1] GB-443 Health Sciences Centre, 820 Sherbrook Street, Winnipeg
关键词
Ulcerative Colitis; Primary Sclerosing Cholangitis; Ulcerative Colitis Patient; Chronic Colitis; Cancer Surveillance;
D O I
10.1007/s11894-999-0010-x
中图分类号
学科分类号
摘要
This article reviews the rationale and approach to dysplasia surveillance colonoscopy in inflammatory bowel disease. Recent developments in the field are also highlighted, including approaches to polyps that arise in patients with colitis and new diagnostic markers that may complement morphologic assessment for dysplasia.
引用
收藏
页码:496 / 504
页数:8
相关论文
共 132 条
[1]  
Gyde SN(1988)Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres Gut 29 206-217
[2]  
Prior P(1990)Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years Gut 31 800-806
[3]  
Allan RN(1990)Colonoscopic surveillance in long-standing total ulcerative colitis: a 15 year follow-up study Gastroenterology 99 1021-1031
[4]  
Lennard-Jones JE(1990)Ulcerative colitis and colorectal cancer: a population-based study N Engl J Med 323 1228-1233
[5]  
Melville DM(1999)Increased risk of cancer in ulcerative colitis: a population-based cohort study Am J Gastroenterol 94 1047-1052
[6]  
Morson BC(1990)Increased risk of large-bowel cancer in Crohn's disease with colonic involvement Lancet 336 357-359
[7]  
Lofberg R(1999)The epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study Am J Epidemiol 149 916-924
[8]  
Brostrom O(1998)Diagnoses of extraintestinal manifestations and cancers in IBD in large population-based databases [abstract] Gastroenterology 114 A930-A930
[9]  
Karlen P(1994)Clinicopathological characteristics of carcinoma complicating ulcerative colitis Gut 35 1419-1423
[10]  
Ekbom A(1995)Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis Am J Gastroenterol 90 2106-2114